NEFL and Spinocerebellar ataxia type 3: These data indicate that previously established progressive motor impairments track with blood NfL increases over the course of disease, thus aligning molecular and behavioral evidence of progressive neurodegeneration in the Q84/Q84 mouse model of SCA3.